Zero Hedge: President Joe Biden’s United States Department of Health and Human Services (HHS) on Thursday stopped executive orders from his predecessor designed to significantly lower prescription drug prices for Americans, including insulin and epinephrine.
The new administration will apparently re-evaluate the executive action from President Donald Trump toward the end of March. It remains unclear if it will be reinstated.
“The HHS Thursday froze the former Trump administration’s December drug policy that requires community health centers to pass on all their insulin and epinephrine discount savings to patients,” Bloomberg Law reported Thursday. “Centers that don’t pass on the savings wouldn’t qualify for federal grants.” Read More